---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-001271"
form_type: "8-K"
ticker: "SBEV"
cik: "0001553788"
company_name: "SPLASH BEVERAGE GROUP, INC."
filed_at: "2026-09-22T20:10:25+00:00"
generated_at: "2026-09-22T20:11:26.963583+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Endovia closes $500K convertible debt financing from C/M Capital for CannEpil development

## Summary
- Closed $500,000 initial secured convertible debt from C/M Capital Master Fund, LP; first tranche of $1M commitment.
- Funds support CannEpil® FDA veterinary program (INAD File No. 14145) and international commercialization.
- Partner Lupvindol Biosciences Ltd. advancing canine oncology pain program; exclusive global rights from Argent BioPharma.
- H.R. 10150 (introduced Aug 27, 2026) proposes 12-year market exclusivity for FDA-approved botanical drugs.
- FDA launched initiative on botanical drug development; company cites growing federal support for cannabis-derived therapies.

## SEC filing metadata
- accession: 0001731122-26-001271
- form_type: 8-K
- ticker: SBEV
- cik: 0001553788
- company_name: SPLASH BEVERAGE GROUP, INC.
- filed_at: 2026-09-22T20:10:25+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553788/000173112226001271/0001731122-26-001271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553788/000173112226001271/e7964_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-001271
- JSON: https://secwatch.observer/filing/0001731122-26-001271.json
- Plain text: https://secwatch.observer/filing/0001731122-26-001271.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.